Insider Transactions in Q2 2025 at Elevation Oncology, Inc. (ELEV)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 16
2025
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
4,627
-3.09%
|
$0
$0.39 P/Share
|
Jun 16
2025
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
12,560
+7.74%
|
-
|
May 15
2025
|
Tammy Furlong CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
784
-7.22%
|
$0
$0.3 P/Share
|
May 15
2025
|
Tammy Furlong CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,643
+19.57%
|
-
|
May 15
2025
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
2,303
-1.65%
|
$0
$0.3 P/Share
|
May 15
2025
|
Joseph J Ferra Jr CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+4.29%
|
-
|